Research articleImpairment in exploratory behavior is associated with arc gene overexpression in the dorsolateral striatum of rats with nigral injection of L-BUTHIONINE (cas 13073-21-7) sulfoximine
-
Add time:09/09/2019 Source:sciencedirect.com
The aims of the present work were to evaluate the exploratory activity in Sprague-Dawley rats, as well as to analyze the nigral and striatal mRNA expression of the plasticity-related genes bdnf and arc after L-BUTHIONINE (cas 13073-21-7) sulfoximine (BSO) injection into substantia nigra compacta. Lesioned rats traveled less distance in open field but did not show a decline in the novel object recognition test. On the other hand, RT-PCR analysis showed overexpression of striatal arc 24 h post-lesion; no significant changes in bdnf expression were observed in nigral or striatal tissue. These results suggest that intranigral BSO injection causes impairment in exploratory behavior in these rats, by affecting locomotion, which is associated with changes in striatal synaptic plasticity.
We also recommend Trading Suppliers and Manufacturers of L-BUTHIONINE (cas 13073-21-7). Pls Click Website Link as below: cas 13073-21-7 suppliers
Prev:Research articleMo-CBP3, a 2S albumin from Moringa oleifera, is a complex mixture of isoforms that arise from different post-translational modifications
Next:Systemic L-BUTHIONINE (cas 13073-21-7)-S-R-sulfoximine administration modulates glutathione homeostasis via NGF/TrkA and mTOR signaling in the cerebellum) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- original paperButhionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines09/30/2019
- Melanin content and downregulation of glutathione S-transferase contribute to the action of L-BUTHIONINE (cas 13073-21-7)-S-sulfoximine on human melanoma09/29/2019
- Original ContributionMechanisms of BSO (L-BUTHIONINE (cas 13073-21-7)-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma09/28/2019
- Potential of L-BUTHIONINE (cas 13073-21-7) sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer☆10/01/2019
- Research reportSensory-motor performance after acute glutathione depletion by L-BUTHIONINE (cas 13073-21-7) sulfoximine injection into substantia nigra pars compacta09/27/2019
- l-S,R-buthionine sulfoximine: historical development and clinical issues09/26/2019
- Thiol modulation and protectionPharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine09/25/2019
- Inhibition of glutathione production by L-S,R-buthionine sulfoximine activates hepatic ascorbate synthesis – A unique anti-oxidative stress mechanism in mice09/24/2019
- Systemic L-BUTHIONINE (cas 13073-21-7)-S-R-sulfoximine administration modulates glutathione homeostasis via NGF/TrkA and mTOR signaling in the cerebellum09/10/2019


